相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management
Cormac McCarthy et al.
LANCET RESPIRATORY MEDICINE (2021)
Serum Vascular Endothelial Growth Factor C as a Marker of Therapeutic Response to Sirolimus in Lymphangioleiomyomatosis
Nishant Gupta et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2021)
Celecoxib in lymphangioleiomyomatosis: results of a phase I clinical trial
Souheil El-Chemaly et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
A phase II clinical trial of the Safety Of Simvastatin (SOS) in patients with pulmonary lymphangioleiomyomatosis and with tuberous sclerosis complex
Vera P. Krymskaya et al.
RESPIRATORY MEDICINE (2020)
Single-Cell Transcriptomic Analysis Identifies a Unique Pulmonary Lymphangioleiomyomatosis Cell
Minzhe Guo et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosis
Nishant Gupta et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Standardization of Spirometry 2019 Update An Official American Thoracic Society and European Respiratory Society Technical Statement
Brian L. Graham et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
A Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with Lymphangioleiomyomatosis
Calvin Lu et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2017)
Recommendations for a Standardized Pulmonary Function Report An Official American Thoracic Society Technical Statement
Bruce H. Culver et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Lymphangioleiomyomatosis Diagnosis and Management: High-Resolution Chest Computed Tomography, Transbronchial Lung Biopsy, and Pleural Disease Management An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guideline
Nishant Gupta et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Sirolimus and Autophagy Inhibition in Lymphangioleiomyomatosis Results of a Phase I Clinical Trial
Souheil El-Chemaly et al.
CHEST (2017)
Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management
Francis X. McCormack et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Effects of Combining Rapamycin and Resveratrol on Apoptosis and Growth of TSC2-Deficient Xenograft Tumors
Anya Alayev et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2015)
Resveratrol as a novel treatment for diseases with mTOR pathway hyperactivation
Anya Alayev et al.
RESVERATROL AND HEALTH (2015)
Resveratrol prevents rapamycin-induced upregulation of autophagy and selectively induces apoptosis in TSC2-deficient cells
Anya Alayev et al.
CELL CYCLE (2014)
Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans
Charles-Henry Cottart et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2014)
St. George's Respiratory Questionnaire Has Longitudinal Construct Validity in Lymphangioleiomyomatosis
Jeffrey J. Swigris et al.
CHEST (2013)
Serum VEGF-D concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial
Lisa R. Young et al.
LANCET RESPIRATORY MEDICINE (2013)
Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
Francis X. McCormack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis
Victoria A. Brown et al.
CANCER RESEARCH (2010)
Serum Vascular Endothelial Growth Factor-D Prospectively Distinguishes Lymphangioleiomyomatosis From Other Diseases
Lisa R. Young et al.
CHEST (2010)
Steady-State Pharmacokinetics and Tolerability of Trans-Resveratrol 2000 mg Twice Daily with Food, Quercetin and Alcohol (Ethanol) in Healthy Human Subjects
Charles la Porte et al.
CLINICAL PHARMACOKINETICS (2010)
Resveratrol Inhibits mTOR Signaling by Promoting the Interaction between mTOR and DEPTOR
Meilian Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The NHLBI lymphangioleiomyomatosis registry - Characteristics of 230 patients at enrollment
JH Ryu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
分享论文
